Want to see SE:KLAR full AI Analyst Report?
Klaria Pharma Holding AB (KLAR) Income Statement
Klaria Pharma Holding AB Income Statement
Last quarter (Q2 2026), Klaria Pharma Holding AB's total revenue was $0.00. In Q2, Klaria Pharma Holding AB's net income was $-12.89M. See Klaria Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 9.00M | $ 2.25M | $ 8.45M | $ 5.87M | $ 6.11M | |
| $ -2.23M | $ 2.25M | $ 8.45M | $ 5.87M | $ -4.85M | |
| $ 18.18M | $ 33.45M | $ 40.30M | $ 61.31M | $ 80.97M | |
| Depreciation and Amortization | $ 11.22M | $ 11.22M | $ 11.04M | $ 11.03M | $ 10.96M |
| $ -9.20M | $ -19.99M | $ -20.81M | $ -44.80M | $ -39.41M | |
| $ -20.42M | $ -31.21M | $ -31.85M | $ -54.97M | $ -50.11M | |
| $ -26.64M | $ -16.52M | $ -3.76M | $ -8.68M | $ -3.44M | |
| $ -47.06M | $ -47.73M | $ -35.84M | $ -63.66M | $ -53.55M | |
| $ -38.90M | $ -47.75M | $ -35.78M | $ -63.77M | $ -53.53M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.21 | $ -0.38 | $ -0.36 | $ -1.10 | $ -0.97 |
| Diluted EPS | $ -0.21 | $ -0.38 | $ -0.36 | $ -1.10 | $ -0.97 |
| Weighted Average Shares Outstanding | 185.24M | 124.62M | 99.40M | 58.10M | 55.25M |
| Weighted Average Shares Outstanding (Diluted) | 185.24M | 124.62M | 100.80M | 58.10M | 55.25M |
Currency in SEK
